Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines

por Wang, Qian, Ding, Wei, Ding, Yihan, Ma, Jingjing, Qian, Zhaoye, Shao, Jingxian, Li, Yufeng
Publicado 2017

Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma

por Wang, Jiru, Wang, Qiuzi, Wei, Bin, Zhou, Yu, Qian, Zhaoye, Gao, Yong, Chen, Xiaofei
Publicado 2019

PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma

por Qian, Zhaoye, Wei, Bin, Zhou, Yu, Wang, Qiuzi, Wang, Jiru, Sun, Yuan, Gao, Yong, Chen, Xiaofei
Publicado 2019

Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment

por Zhang, Li, Yao, Mengchu, Yan, Wei, Liu, Xiaoning, Jiang, Baofei, Qian, Zhaoye, Gao, Yong, Lu, Xiao-jie, Chen, Xiaofei, Wang, Qi-long
Publicado 2017

Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma

por Wei, Bin, Han, Qin, Xu, Lijuan, Zhang, Xiaohui, Zhu, Jing, Wan, Li, Jin, Yan, Qian, Zhaoye, Wu, Jingjing, Gao, Yong, Zhou, Jianwei, Chen, Xiaofei
Publicado 2015